Anemia in Ugandan pregnant women: a cross-sectional, systematic review and meta-analysis study.
Anemia
Pregnancy
Uganda
Journal
Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093
Informations de publication
Date de publication:
01 Mar 2021
01 Mar 2021
Historique:
received:
29
10
2020
accepted:
19
02
2021
entrez:
2
3
2021
pubmed:
3
3
2021
medline:
3
3
2021
Statut:
epublish
Résumé
Anemia in pregnancy represents a global public health concern due to wide ranging maternal and neonatal adverse outcomes in all peripartum periods. We estimated the prevalence and factors associated with anemia in pregnancy at a national obstetrics and gynecology referral hospital in Uganda and in addition performed a systematic review and meta-analysis of the overall burden of anemia in pregnancy in Uganda. We conducted a cross-sectional study among 263 pregnant women attending the antenatal care clinic of Kawempe National Referral Hospital, Kampala, Uganda, in September 2020. Anemia in pregnancy was defined as a hemoglobin level of < 11.0 g/dl and microcytosis as a mean corpuscular volume (MCV) of < 76 fL. We also performed a systematic review (PROSPERO Registration ID: CRD42020213001) and meta-analysis of studies indexed on MEDLINE, Embase, African Journal Online, ClinicalTrials.gov , ICTRP, and the Cochrane Library of systematic review between 1 January 2000 and 31 September 2020 reporting on the prevalence of anemia in pregnancy in Uganda. The prevalence of anemia was 14.1% (n= 37) (95%CI 10.4-18.8), of whom 21 (56.8%) had microcytic anemia. All cases of anemia occurred in the second or third trimester of pregnancy and none were severe. However, women with anemia had significantly lower MCV (75.1 vs. 80.2 fL, p<0.0001) and anthropometric measurements, such as weight (63.3 vs. 68.9kg; p=0.008), body mass index (25.2 vs. 27.3, p=0.013), hip (98.5 vs. 103.8 cm, p=0.002), and waist (91.1 vs. 95.1 cm, p=0.027) circumferences and mean systolic blood pressure (BP) (118 vs 125 mmHg, p=0.014). Additionally, most had BP within the normal range (59.5% vs. 34.1%, p=0.023). The comparison meta-analysis of pooled data from 17 published studies of anemia in pregnancy in Uganda, which had a total of 14,410 pregnant mothers, revealed a prevalence of 30% (95% CI 23-37). Despite our study having a lower prevalence compared to other studies in Uganda, these findings further confirm that anemia in pregnancy is still of public health significance and is likely to have nutritional causes, requiring targeted interventions. A larger study would be necessary to demonstrate potential use of basic clinical parameters such as weight or blood pressure as screening predictors for anemia in pregnancy.
Sections du résumé
BACKGROUND
BACKGROUND
Anemia in pregnancy represents a global public health concern due to wide ranging maternal and neonatal adverse outcomes in all peripartum periods. We estimated the prevalence and factors associated with anemia in pregnancy at a national obstetrics and gynecology referral hospital in Uganda and in addition performed a systematic review and meta-analysis of the overall burden of anemia in pregnancy in Uganda.
METHODS
METHODS
We conducted a cross-sectional study among 263 pregnant women attending the antenatal care clinic of Kawempe National Referral Hospital, Kampala, Uganda, in September 2020. Anemia in pregnancy was defined as a hemoglobin level of < 11.0 g/dl and microcytosis as a mean corpuscular volume (MCV) of < 76 fL. We also performed a systematic review (PROSPERO Registration ID: CRD42020213001) and meta-analysis of studies indexed on MEDLINE, Embase, African Journal Online, ClinicalTrials.gov , ICTRP, and the Cochrane Library of systematic review between 1 January 2000 and 31 September 2020 reporting on the prevalence of anemia in pregnancy in Uganda.
RESULTS
RESULTS
The prevalence of anemia was 14.1% (n= 37) (95%CI 10.4-18.8), of whom 21 (56.8%) had microcytic anemia. All cases of anemia occurred in the second or third trimester of pregnancy and none were severe. However, women with anemia had significantly lower MCV (75.1 vs. 80.2 fL, p<0.0001) and anthropometric measurements, such as weight (63.3 vs. 68.9kg; p=0.008), body mass index (25.2 vs. 27.3, p=0.013), hip (98.5 vs. 103.8 cm, p=0.002), and waist (91.1 vs. 95.1 cm, p=0.027) circumferences and mean systolic blood pressure (BP) (118 vs 125 mmHg, p=0.014). Additionally, most had BP within the normal range (59.5% vs. 34.1%, p=0.023). The comparison meta-analysis of pooled data from 17 published studies of anemia in pregnancy in Uganda, which had a total of 14,410 pregnant mothers, revealed a prevalence of 30% (95% CI 23-37).
CONCLUSIONS
CONCLUSIONS
Despite our study having a lower prevalence compared to other studies in Uganda, these findings further confirm that anemia in pregnancy is still of public health significance and is likely to have nutritional causes, requiring targeted interventions. A larger study would be necessary to demonstrate potential use of basic clinical parameters such as weight or blood pressure as screening predictors for anemia in pregnancy.
Identifiants
pubmed: 33648575
doi: 10.1186/s41182-021-00309-z
pii: 10.1186/s41182-021-00309-z
pmc: PMC7919073
doi:
Types de publication
Journal Article
Langues
eng
Pagination
19Subventions
Organisme : FIC NIH HHS
ID : D43 TW011401
Pays : United States
Références
J Health Popul Nutr. 2019 Dec 13;38(1):44
pubmed: 31836026
Best Pract Res Clin Obstet Gynaecol. 2012 Feb;26(1):3-24
pubmed: 22138002
Ethiop J Health Sci. 2015 Apr;25(2):155-62
pubmed: 26124623
Trop Med Int Health. 2015 Sep;20(9):1201-1208
pubmed: 25976017
Am J Med Sci. 2019 Sep;358(3):191-199
pubmed: 31331612
J Matern Fetal Neonatal Med. 2018 Oct;31(19):2594-2598
pubmed: 28697657
Mymensingh Med J. 2013 Apr;22(2):370-6
pubmed: 23715364
Trans R Soc Trop Med Hyg. 2007 Sep;101(9):899-907
pubmed: 17555783
PLoS One. 2013 Sep 04;8(9):e73073
pubmed: 24023811
J Blood Med. 2020 Jan 20;11:13-18
pubmed: 32021527
Lancet Glob Health. 2013 Jul;1(1):e16-25
pubmed: 25103581
Curr Dev Nutr. 2020 Apr 25;4(5):nzaa075
pubmed: 32440638
Antimicrob Agents Chemother. 2015 Sep;59(9):5475-82
pubmed: 26124154
Public Health Nutr. 2015 Jun;18(8):1423-35
pubmed: 25222882
Int J Reprod Med. 2020 Jun 26;2020:8053939
pubmed: 32685438
J Blood Med. 2019 Oct 22;10:351-357
pubmed: 31695541
Clin Lab Med. 2013 Jun;33(2):281-91
pubmed: 23702118
Rural Remote Health. 2013 Apr-Jun;13(2):2259
pubmed: 23679828
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Ann Trop Med Parasitol. 2000 Jan;94(1):7-13
pubmed: 10723519
BMC Pregnancy Childbirth. 2016 Apr 11;16:76
pubmed: 27067390
BMC Pregnancy Childbirth. 2016 Jan 28;16:24
pubmed: 26821716
Malar Res Treat. 2010;2010:913857
pubmed: 22347669
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
Paediatr Perinat Epidemiol. 2014 May;28(3):213-26
pubmed: 24506330
Front Cardiovasc Med. 2020 Apr 15;7:59
pubmed: 32351977
Ann N Y Acad Sci. 2000;900:125-36
pubmed: 10818399
BMC Res Notes. 2014 Oct 10;7:712
pubmed: 25304187
Trop Med Int Health. 2006 Oct;11(10):1576-84
pubmed: 17002732
Clin Infect Dis. 2010 Feb 15;50(4):531-40
pubmed: 20067426
Transfusion. 2015 Dec;55(12):2799-806
pubmed: 26246160
Trop Med Int Health. 2013 Dec;18(12):1488-97
pubmed: 24118432
BMC Res Notes. 2017 Oct 25;10(1):510
pubmed: 29070052
BMC Hematol. 2018 Dec 22;18:37
pubmed: 30607249
BMC Public Health. 2019 Dec 30;19(1):1757
pubmed: 31888579
PLoS One. 2020 Aug 7;15(8):e0237407
pubmed: 32764806
Am J Trop Med Hyg. 2008 Dec;79(6):856-63
pubmed: 19052293
Malar J. 2015 Sep 26;14:372
pubmed: 26410081
Obstet Gynecol Surv. 2017 Dec;72(12):730-737
pubmed: 29280474
S Afr Med J. 2017 Jun 30;107(7):606-610
pubmed: 29025451